Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01686 |
| Species: | Homo sapiens |
| Position : | chr16:54926631-54929466 |
| Year: | 2024 |
| Title: | Focal deletions of a promoter tether activate the IRX3 oncogene in T-cell acute lymphoblastic leukemia |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Disease |
| Disease Name: | T-cell acute lymphoblastic leukemia |
| PMID: | 39316719 |
| MONDO: | MONDO:0004947 |
| Tissue: | Blood |
| Tissue Ontology ID: | UBERON:0000178 |
| Cell Source: | T-ALL cells |
| CVCL ID: | |
| Cell Type: | T lymphoblast |
| Cell Ontology ID: | CL:0002419 |
| Experiment Type: | Chromatin conformation capture, Histone modification ChIP-sequencing |
| High Throughput Method: | UMI-4C, H3K27ac HiChIP, H3K27ac ChIP-seq |
| Low Throughput Method: | qRT-PCR, and ChIP-qPCR |
| Target gene : | H3K27AC |
| TF name : |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|